CIK 0000897448
- Accelerated filer
AMARIN CORP PLC\UK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-24 | Kennedy Joseph T General Counsel | Sale | −609,115 | $17.66 | $10.8M | 0 |
| 2019-01-23 | Kennedy Joseph T General Counsel | Sale | −255,779 | $17.95 | $4.6M | 217,934 |
| 2019-01-22 | Kennedy Joseph T General Counsel | Sale | −175,300 | $17.92 | $3.1M | 217,934 |
| 2019-01-11 | Kennedy Joseph T General Counsel | Sale | −3,173 | $18.92 | $60K | 217,934 |
| 2019-01-10 | Zakrzewski Joseph S Director | Sale | −100,000 | $16.00 | $1.6M | 184,547 |
| 2019-01-10 | Zakrzewski Joseph S Director | Sale | −100,000 | $17.96 | $1.8M | 84,547 |
| 2019-01-10 | STACK DAVID M Director | Sale | −26,932 | $18.00 | $485K | 0 |
| 2019-01-10 | STACK DAVID M Director | Sale | −98,572 | $18.00 | $1.8M | 0 |
| 2019-01-10 | Ekman Lars Director | Sale | −21,200 | $14.92 | $316K | 119,216 |
| 2019-01-10 | Ekman Lars Director | Sale | −7,247 | $15.96 | $116K | 111,969 |
| 2019-01-10 | Ekman Lars Director | Sale | −48,711 | $17.29 | $842K | 63,258 |
| 2019-01-10 | Ekman Lars Director | Sale | −55,762 | $18.16 | $1.0M | 7,496 |
| 2019-01-10 | Ekman Lars Director | Sale | −7,496 | $18.62 | $140K | 0 |
| 2019-01-09 | Kalb Michael Wayne SVP and CFO | Sale | −200,000 | $15.26 | $3.1M | 17,486 |
| 2019-01-02 | Zakrzewski Joseph S Director | Sale | −385,000 | $13.03 | $5.0M | 84,547 |
| 2018-12-31 | Kennedy Joseph T General Counsel | Sale | −26,943 | $13.49 | $364K | 217,934 |
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Sale | −17,041 | $13.51 | $230K | 341,297 |
| 2018-12-28 | Zakrzewski Joseph S Director | Sale | −141,500 | $13.19 | $1.9M | 84,547 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Sale | −17,042 | $17.79 | $303K | 341,297 |
| 2018-11-30 | Kennedy Joseph T General Counsel | Sale | −23,306 | $17.81 | $415K | 217,934 |
Page 4 of 14 · 279 trades